CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Can-Fite BioPharma Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$1.89+0.13 (+7.39%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Can-Fite BioPharma has not reported a dividend
No dividend per share appears in Can-Fite BioPharma's annual filings since fiscal 2014.